U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...